In This Section
Recent Events

View all events

Nizatidine

For the treatment of the following diseases where reduction of gastric acid is indicated:

  • Duodenal ulcer.
  • Benign gastric ulcer.
  • Prevention of duodenal or benign gastric ulcer recurrence.
  • Gastric oesophageal reflux disease (including erosions, ulcerations and associated heartburn).
  • Gastric and/or duodenal ulcer associated with concomitant use of non-steroidal anti-inflammatory drugs.

Nizatidine
Product type:

H2 antagonist


Availability:

Prescription Only (POM)


Available as:
Capsule:

150mg, 300mg

Advice
Please contact your doctor or pharmacist for further advice.
Thank you for letting us use cookies to improve your experience. For more information on the cookies we use see our privacy policy.